Author

Verena Sturmlehner

Innsbruck Medical UniversityORCID 0009-0006-7957-7321Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Assay:long-read sequencing· 1

Frequent Co-Authors

Antonia DegeniD· 1 shared Christian PloneriD· 1 shared Daniela KaralliD· 1 shared Hamed Homaei RadiD· 1 shared Judith HagenbuchneriD· 1 shared Lukas NeumanniD· 1 shared Michael J. AusserlechneriD· 1 shared Sara TucciiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Antonia DegenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologybioRxivPreprintSep 22, 2026

✦ In-depth digest

Naloxone as mitochondrial phenotype rescuer in a 3D bioprinted LCHADD/VLCADD model

Antonia Degen, Michael J. Ausserlechner, Verena Sturmlehner…·Judith Hagenbuchner

Naloxone, a NOX2 inhibitor, largely restored mitochondrial networks and curbed a pro-fibrotic signature in LCHADD/VLCADD patient fibroblasts, and rescued impaired vessel formation in 3D bioprinted vascularized constructs.

DOI 10.64898/2026.09.07.749837

humanbulk RNA-seq

𝕏 PostBluesky